Suberoylanilide Hydroxamic Acid Potentiates Apoptosis, Inhibits Invasion, and Abolishes Osteoclastogenesis by Suppressing Nuclear Factor-κB Activation

This publication has 62 references indexed in Scilit:

• Cyclooxygenase (COX)-2 Inhibitor Celecoxib Abrogates Activation of Cigarette Smoke-Induced Nuclear Factor (NF)-κB by Suppressing Activation of I-κB α Kinase in Human Non-Small Cell Lung Carcinoma
  Cancer Research, 2004
• Protein Farnesyltransferase Inhibitor (SCH 66336) Abolishes NF-κB Activation Induced by Various Carcinogens and Inflammatory Stimuli Leading to Suppression of NF-κB-regulated Gene Expression and Up-regulation of Apoptosis
  Journal of Biological Chemistry, 2004
• Identification of a p65 Peptide That Selectively Inhibits NF-κ B Activation Induced by Various Inflammatory Stimuli and Its Role in Down-regulation of NF-κB-mediated Gene Expression and Up-regulation of Apoptosis
  Journal of Biological Chemistry, 2004
• Signalling pathways of the TNF superfamily: a double-edged sword
  Nature Reviews Immunology, 2003
• Genetic Deletion of the Tumor Necrosis Factor Receptor p60 or p80 Sensitizes Macrophages to Lipopolysaccharide-induced Nuclear Factor-κB, Mitogen-activated Protein Kinases, and Apoptosis
  Published by Elsevier ,2003
• p53 stabilization is decreased upon NFκB activation
  Cancer Cell, 2002
• Nuclear transcription factor-κB as a target for cancer drug development
  Leukemia, 2002
• Inhibition of NF-κB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicin
  Oncogene, 2001
• Activators and target genes of Rel/NF-κB transcription factors
  Oncogene, 1999
• NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune Responses
  Annual Review of Immunology, 1998